Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
iTL creates its targeting constructs by using the high-fidelity Red/ET recombineering method. We isolate genomic BACs from our internal library, and use homologous recombination to produce the vectors. By comparison to the traditional PCR-based process, BAC recombineering is much less likely to introduce unwanted mutations.
